Consistent with this, the suppression of GATA3 has been shown to improve the adipogenesis process, restore insulin sensitivity, and reduce obesity-associated inflammation in patients with obesity (57). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.